| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.70B | 7.84B | 7.02B | 7.88B | 8.35B | 5.97B |
| Gross Profit | 1.68B | 1.83B | 1.58B | 1.90B | 2.05B | 1.24B |
| EBITDA | 1.03B | 1.06B | 1.01B | 1.31B | 1.33B | 819.90M |
| Net Income | 261.15M | 183.89M | 143.18M | 383.26M | 520.69M | 125.52M |
Balance Sheet | ||||||
| Total Assets | 8.48B | 8.89B | 8.60B | 8.68B | 9.42B | 8.74B |
| Cash, Cash Equivalents and Short-Term Investments | 997.67M | 907.83M | 623.12M | 675.03M | 995.03M | 827.98M |
| Total Debt | 4.46B | 4.37B | 4.28B | 4.12B | 4.41B | 4.52B |
| Total Liabilities | 5.51B | 5.73B | 5.23B | 5.14B | 5.78B | 5.67B |
| Stockholders Equity | 2.96B | 3.16B | 3.37B | 3.55B | 3.64B | 3.07B |
Cash Flow | ||||||
| Free Cash Flow | 955.01M | 771.68M | 308.17M | 1.07B | 468.55M | -218.32M |
| Operating Cash Flow | 1.23B | 1.19B | 746.98M | 1.51B | 1.03B | 444.71M |
| Investing Cash Flow | -314.09M | -396.31M | -393.31M | -868.26M | -458.99M | -726.82M |
| Financing Cash Flow | -80.82M | -341.05M | -251.56M | -865.38M | -460.31M | 510.88M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$20.23B | 4.32 | 14.24% | 5.87% | 14.76% | 23.04% | |
75 Outperform | HK$775.00M | 7.09 | 21.11% | 8.89% | -8.00% | -11.37% | |
67 Neutral | HK$2.90B | 4.54 | 8.10% | 4.00% | 3.40% | 151.24% | |
64 Neutral | HK$2.62B | 1.52 | 14.74% | 12.14% | -0.95% | 2.58% | |
63 Neutral | HK$1.95B | 2.63 | 12.21% | 7.98% | 13.52% | 4.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | HK$1.76B | 6.53 | 4.73% | 8.06% | -2.44% | -5.98% |